-
01
COMPANY PROFILE
公司概況
-
南京博天科智生物技術有限公司作為國內體外診斷試劑生產企業，前身由南京醫科大學、江蘇省人民醫院及江蘇省科教興衛工程高技術平臺學科梯隊組建，是集研發、生產和銷售于一體的高科技生物技術公司，著重于體外診斷產品的自主研發；產品主要涉及心血管疾病和惡性腫瘤領域等，獲得多項國家級科技獎，國家發明及實用新型專利授權多項。
As a domestic manufacturer of in vitro diagnostic reagents, Nanjing Botian Kezhi Biotechnology co., ltd. was formerly established by Nanjing Medical University, Jiangsu Provincial People's Hospital and Jiangsu Province Science and Education Rehabilitation Engineering Hi-tech Platform discipline echelon.It is a high-tech biotechnology company integrating research and development, production and sales,focuses on the independent research and development of in vitro diagnostic products.The products are mainly related to cardiovascular diseases and malignant tumors, and have won a number of national science and technology awards, and many national invention and utility model patents.
-
02
COMPANY DEVELOPMENT
發展歷史
-
2006年：公司成立；
2008年：獲得醫療器械生產許可證；
2009-2012年：cTnI、H-FABP等產品相繼上市；
2013-2016年：開展無創體外診斷試劑的研發；
2017年：獲得天使基金；
2018年：無創體外診斷產品臨床試驗及注冊；
2019年：公司重組，引進戰略投資人；
2021年：獲得國家高新技術企業稱號
The company was established in 2006;
obtained a medical device production license in 2008;
cTnI, H-FABP and other products were successively marketed from 2009 to 2012;
R & D of non-invasive in vitro diagnostic reagents was carried out from 2013 to 2016;
angel fund was obtained in 2017;
Clinical trials and registration of diagnostic products in 2018;
company restructuring and introduction of strategic investors in 2019.
Won the title of national high-tech enterprise in 2021
-
03
COMPANY CULTURE
企業文化
-
我們的宗旨：科學創新、厚積薄發、嚴密質控、服務至上
我們的理念：無創、快速、精準
我們的使命：專業、呵護生命Our aim: scientific innovation, accumulation of wealth, strict quality control, service first
Our philosophy: non-invasive, fast and accurate
Our mission: professional, care for life